ICD-10-CM Billable Code

H35.23

Other non-diabetic proliferative retinopathy, bilateral

Clinical Classification Guidelines

Medical Intelligence & Overview

Non-diabetic proliferative retinopathy is a condition characterized by abnormal growth of blood vessels in the retina, the light-sensitive tissue at the back of the eye. Specifically, when this abnormal proliferation occurs due to reasons other than diabetes and affects both eyes, it is classified under ICD-10 code H35.23. This condition can lead to vision problems and requires proper medical assessment for management.

Causes & Symptoms

Clinical Causes: Retinal vein occlusions Sickle cell retinopathy Radiation exposure Inherited retinal diseases Inflammatory eye conditions other ocular or systemic disorders affecting retinal circulation

Key Symptoms: Gradual loss of central or peripheral vision Blurred vision Dark spots or floaters in the visual field Sudden vision loss in severe cases Visual distortions, such as straight lines appearing crooked

Diagnostic & Treatment

Diagnosis Path: Dilated fundus examination to visualize abnormal blood vessel growth Fluorescein angiography to identify areas of neovascularization Optical coherence tomography (OCT) to assess retinal structure Visual acuity testing to determine impact on vision

Treatment Protocols: Laser photocoagulation therapy to destroy abnormal blood vessels and reduce risk of bleeding Intravitreal injections of anti-VEGF agents to inhibit blood vessel growth Frequent eye monitoring for early detection of changes Addressing underlying systemic conditions, if applicable, to optimize ocular health

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H35.23 a billable ICD-10 code?
Yes, H35.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H35.23?
Clinical documentation must specify the nature of Other non-diabetic proliferative retinopathy, bilateral and any associated comorbidities for accurate reporting.

Cite this Clinical Reference